| # | Drug | Count |
|---|---|---|
| 0 | OXYCODONE | 181 |
| 1 | OXYCODONE HYDROCHLORIDE | 168 |
| 2 | PALBOCICLIB | 167 |
| 3 | LENALIDOMIDE | 157 |
| 4 | DEXAMETHASONE | 144 |
| 5 | DEXAMETHASONE 1.5 MG | 143 |
| 6 | ACETAMINOPHEN | 138 |
| 7 | GABAPENTIN | 134 |
| 8 | CABOZANTINIB | 131 |
| 9 | DENOSUMAB | 127 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RADIUM RA 223 DICHLORIDE | 32 | 0.0063 |
| 1 | NALDEMEDINE | 10 | 0.0060 |
| 2 | CABAZITAXEL | 12 | 0.0034 |
| 3 | TRIFLURIDINE AND TIPIRACIL | 36 | 0.0033 |
| 4 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 25 | 0.0033 |
| 5 | ENFORTUMAB VEDOTIN | 25 | 0.0032 |
| 6 | FULVESTRANT | 97 | 0.0029 |
| 7 | RIPRETINIB | 15 | 0.0029 |
| 8 | BICALUTAMIDE | 43 | 0.0028 |
| 9 | REGORAFENIB | 32 | 0.0028 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 355 |
| 1 | Corticosteroid [EPC] | 293 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 280 |
| 3 | Opioid Agonist [EPC] | 276 |
| 4 | Thalidomide Analog [EPC] | 186 |
| 5 | Benzodiazepine [EPC] | 185 |
| 6 | Platinum-based Drug [EPC] | 156 |
| 7 | Proton Pump Inhibitor [EPC] | 150 |
| 8 | Aromatase Inhibitor [EPC] | 148 |
| 9 | Androgen Receptor Inhibitor [EPC] | 136 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 3 | 0.0028 |
| 1 | Estrogen Receptor Antagonist [EPC] | 112 | 0.0028 |
| 2 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 3 | Androgen Receptor Inhibitor [EPC] | 136 | 0.0018 |
| 4 | Antifibrinolytic Agent [EPC] | 15 | 0.0015 |
| 5 | Aromatase Inhibitor [EPC] | 148 | 0.0013 |
| 6 | Phenothiazine [EPC] | 38 | 0.0013 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 120 | 0.0012 |
| 8 | Lipid Emulsion [EPC] | 3 | 0.0011 |
| 9 | Benzodiazepine Antagonist [EPC] | 1 | 0.0011 |